S. Gail Eckhardt named to key roles in experimental therapeutics, translational research at Baylor

Pan-cancer proteogenomics reveals potential drug targets

Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets.

June 28, 2024

Vol.50 No.26

Clinical Roundup

PKMYT1 is a potential target for treatment-resistant ER+ breast cancers

Up to 80% of breast cancer deaths occur in patients with tumors that express estrogen receptor-alpha, according to a study published in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.

May 31, 2024

Vol.50 No.22

In Brief

Shanda Blackmon named director of Baylor’s Lung Institute

Shanda H. Blackmon was named director of the Lung Institute at Baylor Medicine.

April 26, 2024

Vol.50 No.17

Clinical Roundup

Novel assay improves detection of potential therapeutic tumor targets in human biopsies

Researchers at Baylor College of Medicine and collaborating institutions developed a kinase inhibitor pulldown assay that can optimally enrich and quantify the small amounts of kinases present in biopsy samples in combination with mass-spectrometry techniques.

January 19, 2024

Vol.50 No.03

In Brief

Baylor’s culinary event raises $6.2 million for cancer research

Chef Chris Haatuft serves guests at the BCM Culinary Stars Shine for Cancer Research.Baylor College of Medicine’s Culinary Stars Shine for Cancer Research event raised $6.2 million to support cancer research at Baylor’s Dan L Duncan Comprehensive Cancer Center.

January 05, 2024

Vol.50 No.01

In Brief

Cancer researchers Henkel Valentine, Kimiko Krieger recognized as IMPACT Fellow by National Postdoctoral Association

Henkel ValentineKimiko KriegerHenkel Valentine and Kimiko Krieger, two cancer scientists, were two of six postdoctoral researchers nationwide recently recognized as an IMPACT Fellow by the National Postdoctoral Association.

November 03, 2023

Vol.49 No.41

S. Gail Eckhardt named to key roles in experimental therapeutics, translational research at Baylor

YOU MAY BE INTERESTED IN

Pan-cancer proteogenomics reveals potential drug targets

PKMYT1 is a potential target for treatment-resistant ER+ breast cancers

Shanda Blackmon named director of Baylor’s Lung Institute

Novel assay improves detection of potential therapeutic tumor targets in human biopsies

Baylor’s culinary event raises $6.2 million for cancer research

Cancer researchers Henkel Valentine, Kimiko Krieger recognized as IMPACT Fellow by National Postdoctoral Association

Renew today!

Subscriber content

Login